What is This Image? 2017: Image 4 Result : Improvement of Ischemia with Statin Therapy

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2017 Dec 3

PMID 29196912

Authors

Ronald G Schwartz

Affiliations

Soon will be listed here.

References

Shaw L, Berman D, Maron D, Mancini G, Hayes S, Hartigan P . Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117(10):1283-91. DOI: 10.1161/CIRCULATIONAHA.107.743963. View

Gould K, Ornish D, Scherwitz L, Brown S, Edens R, Hess M . Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995; 274(11):894-901. DOI: 10.1001/jama.1995.03530110056036. View

Treasure C, Klein J, Weintraub W, Talley J, Stillabower M, Kosinski A . Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332(8):481-7. DOI: 10.1056/NEJM199502233320801. View

Brown B, Zhao X, Chait A, Fisher L, Cheung M, Morse J . Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2002; 345(22):1583-92. DOI: 10.1056/NEJMoa011090. View

Schwartz R, Kudes M . Monitoring effectiveness of medical therapy in 2006. J Nucl Cardiol. 2006; 13(2):184-90. DOI: 10.1007/BF02971242. View

Libby P . Bone marrow: a fountain of vascular youth?. Circulation. 2003; 108(4):378-9. DOI: 10.1161/01.CIR.0000084801.04026.7B. View

Gould K, Martucci J, GOLDBERG D, Hess M, Edens R, Latifi R . Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation. 1994; 89(4):1530-8. DOI: 10.1161/01.cir.89.4.1530. View

Schwartz R, PEARSON T . Can single photon emission computed tomography myocardial perfusion imaging monitor the potential benefit of aggressive treatment of hyperlipidemia?. J Nucl Cardiol. 1998; 4(6):555-68. DOI: 10.1016/s1071-3581(97)90016-7. View

Schwartz R, Pearson T, Kalaria V, Mackin M, Williford D, Awasthi A . Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol. 2003; 42(4):600-10. DOI: 10.1016/s0735-1097(03)00767-8. View

10.

Huggins G, Pasternak R, Alpert N, Fischman A, GEWIRTZ H . Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation. 1998; 98(13):1291-6. DOI: 10.1161/01.cir.98.13.1291. View